Best Prospects in the Global Radiopharmaceuticals Market and Strategies for Growth – Includes Radiopharmaceuticals Market Size
The Business Research Company’s report goes into great detail on the radiopharmaceuticals market size and growth, radiopharmaceuticals market regional analysis, radiopharmaceuticals market competitive landscape, and other critical information needed to excel in the radiopharmaceuticals industry.
Major players in the radiopharmaceuticals market include Cardinal Health, Curium Pharma, Siemens Healthineers AG, Novartis AG, General Electric Company (GE)
TBRC’s comprehensive market report based on extensive research will assist you in seamlessly devising your approaches in order to match key market player strategies.
The radiopharmaceuticals market is expected to grow from $4.29 billion in 2020 to $5.71 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The radiopharmaceuticals market is then expected to grow at a CAGR of 5.6% from 2025 and reach $7.50 billion in 2030.
North America was the largest region in the global radiopharmaceuticals market, accounting for 41.6% of the total in 2021.
The radiopharmaceuticals market consists of sales of radiopharmaceuticals and related services by entities (organizations, sole traders, and partnerships) that produce radiopharmaceuticals used in diagnosing and/or treating cancer, cardiovascular diseases, and other diseases. Radiopharmaceuticals are radioactive compounds administered to the patients, monitored via specific imaging devices, and used for diagnostic and therapeutic purposes.
Increasing aging population is expected to increase the prevalence of age-related ailments thus contributing to the growth of the radiopharmaceuticals market
Request a Sample of the Radiopharmaceuticals Market Report
Research collaborations and partnerships are gaining significant popularity in the radiopharmaceuticals market over recent years. Major companies operating in the radiopharmaceuticals market are collaborating with other industry players to conduct R&D activities to expand their business.
TBRC’s Global Radiopharmaceuticals Market Report Is Segmented:
By Type: Diagnostic, Therapeutic, Others
By Application: Oncology, Cardiology, Neuroendocrinnology, Neurology, Nephrology, Musculoskeletal, Others
By End-User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes.
By Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
The Radiopharmaceuticals Market Report 2022 is one of a series of new reports from The Business Research Company that provides an overview of the radiopharmaceuticals market globally and regionally, analyzes and forecasts market size, share, radiopharmaceuticals market players, radiopharmaceuticals market segments, leading competitor revenues, profiles and market shares.
Here Is A List Of Similar Reports From The Business Research Company:
Pharmaceuticals Global Market Report 2022
Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
